U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 18 results

Status:
US Approved Rx (2008)
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dorzolamide is a sulfonamide and a highly specific carbonic anhydrase II (CA-II) inhibitor, which is the main CA isoenzyme involved in aqueous humor secretion. Dorzolamide is marketed under the trade name Trusopt, indicated in the treatment of elevat...
Status:
US Approved Rx (1995)
First approved in 1986

Class (Stereo):
CHEMICAL (RACEMIC)



Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory drug that exhibits antiinflammatory, analgesic, and antipyretic activities in animal models. Flurbiprofen Tablets are indicated for relief of the signs and symptoms of rh...
Status:
US Approved Rx (1993)
First approved in 1959

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methazolamide is topical carbonic anhydrase inhibitor. Methazolamide is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. Metha...
Status:
US Approved Rx (1958)
First approved in 1958

Class (Stereo):
CHEMICAL (ACHIRAL)



Diclorphenamide, a carbonic anhydrase inhibitor, was initially developed for the treatment of glaucome, however, now it is used for patients suffering from primary hypokalemic and hyperkalemic periodic paralysis. The exact mechanism of diclorphenamid...
Status:
US Approved Rx (2008)
First approved in 1953

Class (Stereo):
CHEMICAL (ACHIRAL)



Acetazolamide, usually sold under the trade name Diamox in some countries. DIAMOX is used for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Sezolamide (previously known as MK-417), a potent carbonic anhydrase inhibitor capable of reducing intraocular pressure after topical application, was under investigation for the treatment of glaucoma. . Sezolamide is the more potent of the two ster...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Propazolamide is a sulfonamide derivative patented by American Cyanamid Co. useful in the treatment of glaucoma and epilepsy and as oral diuretics. Propazolamide acts as a carbonic anhydrase inhibitor.
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Sulfonamide derivative Disulfamide was developed as diuretic agent.
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)


Indisulam (also known as E7070) is a sulfonamide derivative patented by Japanese pharmaceutical company Eisai Co. as antitumor agent. Indisulam inhibits cyclin-dependent kinases (CDK), which regulate cell cycle progression and are usually over-expre...

Showing 1 - 10 of 18 results